Trademark Attorney / Law Firm

Samir Inc. - Patel – Trademark Portfolio

Samir Inc. - Patel specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 2 of 3 total filings concentrated in this category. The practice also covers Class 44 (Medical Services) along with 2 other Nice Classification classes. Filing activity spans from 2025 to 2026. Currently, 1 trademark is registered and 2 are pending.

3 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

Samir Inc. - Patel's trademark practice covers 2 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademark applications has Samir Inc. - Patel filed?

Samir Inc. - Patel has filed 3 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 2 pending.

What trademark classes does Samir Inc. - Patel specialize in?

Samir Inc. - Patel has filed trademarks across 2 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

How long has Samir Inc. - Patel been filing trademarks?

Samir Inc. - Patel's trademark filing history with the USPTO spans from 2025 to 2026, covering 1 year of trademark practice. During this period, Samir Inc. - Patel has handled 3 trademark applications.

What is Samir Inc. - Patel's trademark registration success rate?

Samir Inc. - Patel has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 2 applications are pending review.